Literature DB >> 23820980

Analysis of HOX gene expression patterns in human breast cancer.

Ho Hur1, Ji-Yeon Lee, Hyo Jung Yun, Byeong Woo Park, Myoung Hee Kim.   

Abstract

HOX genes are highly conserved transcription factors that determine the identity of cells and tissues along the anterior-posterior body axis in developing embryos. Aberrations in HOX gene expression have been shown in various tumors. However, the correlation of HOX gene expression patterns with tumorigenesis and cancer progression has not been fully characterized. Here, to analyze putative candidate HOX genes involved in breast cancer tumorigenesis and progression, the expression patterns of 39 HOX genes were analyzed using breast cancer cell lines and patient-derived breast tissues. In vitro analysis revealed that HOXA and HOXB gene expression occurred in a subtype-specific manner in breast cancer cell lines, whereas most HOXC genes were strongly expressed in most cell lines. Among the 39 HOX genes analyzed, 25 were chosen for further analysis in malignant and non-malignant tissues. Fourteen genes, encoding HOXA6, A13, B2, B4, B5, B6, B7, B8, B9, C5, C9, C13, D1, and D8, out of 25 showed statistically significant differential expression patterns between non-malignant and malignant breast tissues and are putative candidates associated with the development and malignant progression of breast cancer. Our data provide a valuable resource for furthering our understanding of HOX gene expression in breast cancer and the possible involvement of HOX genes in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23820980     DOI: 10.1007/s12033-013-9682-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  25 in total

Review 1.  Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications.

Authors:  Brent N Rexer; Carlos L Arteaga
Journal:  Crit Rev Oncog       Date:  2012

Review 2.  Hox proteins meet more partners.

Authors:  R S Mann; M Affolter
Journal:  Curr Opin Genet Dev       Date:  1998-08       Impact factor: 5.578

3.  A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer.

Authors:  Pamela J Boimel; Cristian Cruz; Jeffrey E Segall
Journal:  Genomics       Date:  2011-06-13       Impact factor: 5.736

4.  Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus.

Authors:  Massimiliano di Pietro; Pierre Lao-Sirieix; Shelagh Boyle; Andy Cassidy; Dani Castillo; Amel Saadi; Ragnhild Eskeland; Rebecca C Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-17       Impact factor: 11.205

Review 5.  Adjuvant endocrine therapy for breast cancer.

Authors:  Ruta D Rao; Melody A Cobleigh
Journal:  Oncology (Williston Park)       Date:  2012-06       Impact factor: 2.990

6.  The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway.

Authors:  Kideok Jin; Xiangjun Kong; Tariq Shah; Marie-France Penet; Flonne Wildes; Dennis C Sgroi; Xiao-Jun Ma; Yi Huang; Anne Kallioniemi; Goran Landberg; Ivan Bieche; Xinyan Wu; Peter E Lobie; Nancy E Davidson; Zaver M Bhujwalla; Tao Zhu; Saraswati Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

7.  Adjuvant trastuzumab in HER2-positive breast cancer.

Authors:  Dennis Slamon; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; Miguel Martin; Michael Press; John Mackey; John Glaspy; Arlene Chan; Marek Pawlicki; Tamas Pinter; Vicente Valero; Mei-Ching Liu; Guido Sauter; Gunter von Minckwitz; Frances Visco; Valerie Bee; Marc Buyse; Belguendouz Bendahmane; Isabelle Tabah-Fisch; Mary-Ann Lindsay; Alessandro Riva; John Crown
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

8.  Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence.

Authors:  A Caré; A Silvani; E Meccia; G Mattia; C Peschle; M P Colombo
Journal:  Oncogene       Date:  1998-06-25       Impact factor: 9.867

9.  Altered HOX gene expression in human skin and breast cancer cells.

Authors:  Terje Svingen; Kathryn F Tonissen
Journal:  Cancer Biol Ther       Date:  2003 Sep-Oct       Impact factor: 4.742

10.  Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

Authors:  Jessica Kao; Keyan Salari; Melanie Bocanegra; Yoon-La Choi; Luc Girard; Jeet Gandhi; Kevin A Kwei; Tina Hernandez-Boussard; Pei Wang; Adi F Gazdar; John D Minna; Jonathan R Pollack
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more
  27 in total

1.  Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.

Authors:  Jong Jin Oh; Seunghyun Park; Sang Eun Lee; Sung Kyu Hong; Sangchul Lee; Hak Min Lee; Jung Keun Lee; Jin-Nyoung Ho; Sungroh Yoon; Seok-Soo Byun
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-13       Impact factor: 4.553

2.  The function of homeobox genes and lncRNAs in cancer.

Authors:  Yingchao Wang; Yuan Dang; Jingfeng Liu; Xiaojuan Ouyang
Journal:  Oncol Lett       Date:  2016-07-21       Impact factor: 2.967

3.  Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis.

Authors:  Yu-Jun Liu; Yu Zhu; Hai-Xia Yuan; Jian-Ping Zhang; Jian-Ming Guo; Zong-Ming Lin
Journal:  Tumour Biol       Date:  2014-12-05

Review 4.  HOX genes and their role in the development of human cancers.

Authors:  Seema Bhatlekar; Jeremy Z Fields; Bruce M Boman
Journal:  J Mol Med (Berl)       Date:  2014-07-05       Impact factor: 4.599

5.  The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation.

Authors:  K Goto; S Ishikawa; R Honma; K Tanimoto; N Sakamoto; K Sentani; N Oue; J Teishima; A Matsubara; W Yasui
Journal:  Oncogene       Date:  2015-12-07       Impact factor: 9.867

6.  Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.

Authors:  Fan Xuan; Mengying Huang; Wen Liu; Hanfei Ding; Liqun Yang; Hongjuan Cui
Journal:  Neuro Oncol       Date:  2015-11-17       Impact factor: 12.300

7.  Cell-type-specific epigenomic variations associated with BRCA1 mutation in pre-cancer human breast tissues.

Authors:  Yuan-Pang Hsieh; Lynette B Naler; Sai Ma; Chang Lu
Journal:  NAR Genom Bioinform       Date:  2022-02-02

8.  HOXB5 Promotes the Proliferation and Invasion of Breast Cancer Cells.

Authors:  Ji-Yeon Lee; Ho Hur; Hyo Jung Yun; Yeejeong Kim; Seoyeon Yang; Seung Il Kim; Myoung Hee Kim
Journal:  Int J Biol Sci       Date:  2015-05-01       Impact factor: 6.580

9.  HOXB7 Overexpression Leads Triple-Negative Breast Cancer Cells to a Less Aggressive Phenotype.

Authors:  Simone Aparecida de Bessa Garcia; Mafalda Araújo; Tiago Pereira; Renata Freitas
Journal:  Biomedicines       Date:  2021-05-05

10.  HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer.

Authors:  Clara Yuri Kim; Yu Cheon Kim; Ji Hoon Oh; Myoung Hee Kim
Journal:  J Cancer       Date:  2021-06-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.